A phase IIb actively controlled study with the TGF-beta-2 inhibitor AP 12009 for recurrent or refractory anaplastic astrocytoma

Bogdahn, U. and Mahapatra, A. and Olyushin, V. E. and Mouli, C. and Parfenov, V. E. and Stockhammer, G. and Ludwig, S. and Wuerth, G. and Heinrichs, H. and Schlingensiepen, K. (2007) A phase IIb actively controlled study with the TGF-beta-2 inhibitor AP 12009 for recurrent or refractory anaplastic astrocytoma. JOURNAL OF CLINICAL ONCOLOGY, 25 (18supp): 2025. ISSN 0732-183X, 1527-7755

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Neurologie
Depositing User: Petra Gürster
Date Deposited: 30 Oct 2020 09:11
Last Modified: 30 Oct 2020 09:11
URI: https://pred.uni-regensburg.de/id/eprint/32599

Actions (login required)

View Item View Item